Delivery Order SPE2DB24D3013-SPE2DB25FFQFP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,483.53 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting military and federal healthcare systems through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $29,864.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is due for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $10,499.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for ultimate completion by June 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits on September 4, 2025, with a ceiling value of $11,202.07. This firm fixed price, non-set-aside delivery order is scheduled for ultimate completion on September 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the contractor's significant role in supporting federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $17,759.51 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded with a completion date of September 9, 2025. The award was made to AmerisourceBergen's corporate office, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lupron Depot 11.25 mg 3-month kits valued at $7,855.98 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through the company's existing...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Lupron Depot 11.25 mg 3-month kits, valued at $4,474.82 with a firm fixed price structure. This competitively awarded delivery order, with no set-aside designation, is scheduled for completion by August 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month treatment kits under a firm fixed-price contract. The award, valued at $47,687.90 and dated April 23, 2025, represents a single delivery order with an ultimate completion date of April 24, 2025. This contract was competitively awarded with no set-aside designation, and performance will be executed from the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,661.96 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was awarded on September 22, 2025 with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's role as a...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQFPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $3,344.81. This delivery order is issued under a firm fixed-price contract type with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to the Defense Logistics Agency Medical Supply Chain. This award operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's portfolio of federal contracts demonstrates extensive experience delivering specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/5/25 |